CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 127 enrolled
Drug / intervention
Nicotine +1 moredrug
Likely dose
Nicotine 7mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01400243
NCT01400243Phase 4Completed
CompareCT.gov

Nicotine for Marijuana Withdrawal

Southern Illinois University Carbondale·interventional·Posted Jul 22, 2011·Updated Apr 30, 2015

In Brief

A Phase 4 clinical trial evaluating Nicotine and Placebo Patch for Marijuana Dependence. Completed, enrolled 127 participants across 1 site.

Detailed Summary

The purpose of this 3-year trial is to test the efficacy of transdermal nicotine patch versus placebo patch on marijuana withdrawal symptoms in cannabis-dependent individuals, using a randomized, double-blind, and placebo-controlled design. This proposal is in response to RFA-DA-10-016(R01) Medications Development for Cannabis-Related Disorders. Consistent with the goals of this RFA, the overall goal of the proposed project is to assess the impact of transdermal nicotine patch (TNP) on marijuana (MJ) withdrawal (negative affect and craving motivated by negative affect) symptoms in MJ-dependent individuals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMarijuana Dependence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 22, 2011
Enrollment StartApr 1, 2011
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 14.9 years ago

Interventions

Nicotinedrug

Nicotine patch 7mg

Placebo Patchdrug

Placebo patch